Viyash Scientific Limited (BOM:512529)

Market Cap	106.69B +114.9%
Revenue (ttm)	35.75B +123.1%
Net Income	2.11B +612.1%
EPS	4.75 +313.3%
Shares Out	436.46M
PE Ratio	51.49
Forward PE	26.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,212
Open	245.20
Previous Close	246.05
Day's Range	242.60 - 247.65
52-Week Range	178.40 - 297.90
Beta	0.98
Analysts	Strong Buy
Price Target	322.25 (+31.83%)
Est. Earnings	Nov 4, 2026

About Viyash Scientific

Viyash Scientific Limited operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally. The company provides active pharmaceutical ingredients, finished dosage formulations, analytical services, and VET formulation services for cattle and poultry. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary o...

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 2,900
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 512529

Financial Performance

In fiscal year 2026, Viyash Scientific's revenue was 34.20 billion, an increase of 13.75% compared to the previous year's 30.07 billion. Earnings were 1.77 billion, an increase of 663.53%.

Analyst Summary

According to 4 analysts, the average rating for 512529 stock is "Strong Buy." The 12-month stock price target is ₹322.25, which is an increase of 31.83% from the latest price.

Price Target

₹322.25

(31.83% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 27, 2026

Data Sources Report a data error